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BACKGROUND: Around 65% of women with cervical carcinoma in Sweden have not attended an organised screening. We therefore
investigated the value of using self-sampling at home in combination with a test for high-risk human papilloma virus (HPV) to increase
participation.
METHODS: A total of 2829 women 30–58 years old, who had not attended the organised screening for X6 years, were recruited.
They were offered self-sampling at home (Qvintip) and recommended to send the collected vaginal fluid to a laboratory for analysis
of the presence of high-risk HPV (Hybrid Capture 2 method).
RESULTS: A total of 39.1% of the women accepted home sampling. These women disclosed a relatively high prevalence of high-risk
HPV, which decreased with age, from 11.1% in women 30–39 years old to 2.9% in women X50 years . Follow-up disclosed
histological cervical intraepithelial neoplasm (CIN) 2–3 lesions in 43.2% of the women with a persistent HPV infection, corresponding
to 2.0% of the total number of participating women. The sensitivity of a single smear to detect the histological CIN 2–3 lesions were
only 52.6%, even if all abnormal smears (atypical squamous cells of unknown significance (ASCUS)–CIN 3)) were included.
CONCLUSION: The use of self-sampling at home in combination with testing for high-risk HPV increases the participation rate of the
organised screening and detects almost twice as many women with pre-malignant cell alterations (CIN 2–3) in comparison those
with a single cytological smear.
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A recent nationwide investigation in Sweden disclosed that around
65% of all cervical carcinomas occur in women not attending the
organised gynaecological screening and that around 25% are found
in women participating in the screening, but with a series of
normal cytological specimens preceding the tumour diagnosis.
Thus, non-participation and the relatively low sensitivity of
cytology are the two major disadvantages associated with the
organised screening (Andrae et al, 2008). Despite this, the
cytological screening has markedly reduced the prevalence of
cervical carcinoma by over 50%, with at present o500 women
diagnosed in Sweden each year (Bergstro ¨m et al, 1999).
When the organised cytological screening was introduced in the
late 1960s, the aetiology of cervical carcinoma was unknown. It is
now established that human papilloma virus (HPV) is the major
factor for tumour transformation and that DNA of oncogenic
(high-risk) HPV types is present in both invasive carcinoma and
the pre-malignant mucosal progenitors. As HPV DNA tests are
more sensitive than cytology to detect pre-malignant alterations in
the cervix, this method is now considered as an adjunct or an
alternative to cytology as a preventative screening method (zur
Hausen 1991; Meijer et al, 2009).
This study was carried out in an attempt to overcome the two
most prominent weaknesses of the organised screening, the non-
optimal participation rate and the relatively low sensitivity of
cytology. Non-participating women were offered the possibility to
self-sample the vaginal fluid at home and to send the collected
material to a laboratory where a test for high-risk HPV was
performed. Women who were HPV positive were admitted to a
gynaecological surgery for further evaluation.
MATERIALS AND METHODS
At the Department of Clinical Cytology, Uppsala University
Hospital, all information regarding the organised gynaecological
screening is collected in a central database (SymPathy, Tieto-
Enator, Malmo ¨, Sweden). From this data base 3000 women, who
were 30–58 years old and had not attended the organised
screening for X6 years, were identified. Among the 3000 women
selected, 171 had to be excluded because of an incorrect address or
a previously performed hysterectomy.
The remaining 2829 women received an information letter and a
form by which they could order a device (Qvintip, Aprovix AB,
Uppsala, Sweden) to be used for self-sampling of the vaginal fluid
at home. The collected material was to be returned in a prepaid
envelope to the laboratory, where a test for high-risk HPV was
performed. After 3 weeks the women received a letter reminding
them to order the self-sampling device. Women who had ordered
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ythe device received a letter after about 2 months reminding them
to perform the self-sampling of the vaginal fluid. A few women
who sent in a sample for analysis more than 3 months after the
launch of the study were not included in the investigation.
All participating women received a return letter with the results
of the HPV analysis. Women who turned out to be HPV positive
were informed that they were going to be called to the Department
of Gynaecology for further examination within 3–6 months.
At the gynaecological surgery, women were examined by
colposcopy and material was collected for histology, cytology
and a repeated HPV test. The histological material was fixed in
10% buffered formalin, embedded in paraffin, sectioned in about
4-m thin sections, which were stained with haematoxylin–eosin
stain. The sections were examined in a light microscope and
grouped into normal (including cervicitis and metaplasia), cervical
intraepithelial neoplasm (CIN) 1 (including condylomas), CIN 2
and CIN 3.
The cytological smears were fixed in 95% ethanol and stained
with Pap stain before examination. The smears were grouped
into normal, atypical squamous cells of unknown significance
(ASCUS), CIN 1, CIN 2 and CIN 3.
The test for high-risk HPV (Hybrid Capture 2, Qiagen AB, Solna,
Sweden) identifies 13 high-risk HPV types (16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59 and 68). The Digene hc2 technique can detect
HPV DNA concentrations over 1pgml
–1, which is proportional to
the light emission of the positive control and corresponds to 5000
HPV genomes per specimen in the well.
RESULTS
The self-sampling device was ordered by 1609 women (56.9%) and
1107 (39.1%) performed sampling of the vaginal fluid and sent the
material to the laboratory for testing for high-risk HPV. An HPV-
positive reaction was obtained in 6.7% (74 out of 1107) of the
samples. There was no significant age difference with regard to
participation rate. However, the HPV prevalence decreased with
age. It was 11.1% in women 30–39 years old and 2.9% in women
X50 years (Table 1).
Most women decided to order the self-sampling device within a
few weeks and after 8 weeks 1600 women had ordered the device.
However, after obtaining the device the decision to collect a
vaginal fluid sample was slower, 970 samples were obtained within
12 weeks, and even after that time occasional samples were sent to
the laboratory (Figure 1).
The 74 women with a high-risk HPV-positive reaction were
admitted to a gynaecological surgery for further examination.
However, at that time seven women had moved out of the county
and four had chosen to visit a midwife surgery. A repeated test for
high-risk HPV, a cervical biopsy and a cytological smear were
obtained in 60 of the 63 remaining women. A persistent high-risk
HPV infection was seen in 73% (44 out of 60) of the women, 43.2%
of which (19 out of 44) showed CIN 2–3 alterations in the cervical
biopsies (Table 2). The prevalence of CIN 2–3 in women with
persistent HPV infection did not show any marked age variations.
It was 40% (8 out of 20) in women X40 years and 45.8% (11 out of
24) in women o40 years.
A biopsy was obtained in 63 of the 74 HPV-positive women and
22 biopsies showed histological CIN 2–3 lesions, corresponding to
2.0% (22 out of 1107) of the total number of women performing
self-sampling of vaginal smear. The prevalence of CIN 2–3 was
2.9% among participating women under 40 years and 1.1% among
women over 40 years.
The cytological smears taken concomitant with the cervical
biopsies at the gynaecological examination showed a normal
picture in 75% (45 out of 60) of the cases and various kinds of cell
alterations (ASCUS–CIN 3) in 25% (15 out of 60). Among the 19
women with CIN 2–3 in the biopsies, the cytological smear was
normal in 47.4% (9 out of 19) of the cases. In only four (21%) of
the cytological slides CIN 2–3 cell alterations were recorded
(Table 3).
DISCUSSION
In countries with an organised gynaecological screening, the
majority of cervical cancer cases occur among women who have
Table 1 Acceptance to perform self-sampling at home and prevalence of high-risk HPV infection in relation to age among 2829 women, 30–58 years old,
who had not attended organised cytological screening for over 6 years
Age
(years)
Total
number of
women
Number of women
performing self-sampling
(%)
Number of high-
risk HPV-positive
women (%)
Number of women with
persistent high-risk HPV
infection (%)
Number of women
with morphological
CIN 2–3 lesions (%)
30–39 984 373 (38) 42 (11.1) 24/33 (73) 11/24 (46)
40–49 968 386 (40) 22 (5.7) 15/18 (83) 7/15 (47)
50–58 877 343 (39) 10 (2.9) 5/9 (56) 1/5 (20)
Total 2829 1107 (39) 74 (6.7) 44/60 (73) 19/44 (43.2)
HPV¼human papilloma virus.
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Figure 1 Illustration of the relationship between ordering a self-sampling
device and the collection of the vaginal fluid at home with respect to time
lapse.
Table 2 Relationship between a high-risk HPV test and the histological
picture in cervical biopsies in 59 women admitted to a gynaecological
reception due to a previous positive HPV test
HPV test
Histology Positive (%) Negative (%) Total (%)
Normal 15 (25 9 (15) 24 (40)
CIN 1 10 (16) 7 (12) 17 (28)
CIN 2–3 19 (32) 0 (0) 19 (32)
Total 44 (73) 16 (27) 60 (100)
HPV¼human papilloma virus.
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(Andrae et al, 2008). Thus, to reduce the number of women with
cervical cancer, an improvement of the participation rate is an
important issue. The offer to non-attending women to self-sample
the vaginal fluid at home and send the collected material for
testing for high-risk HPV seems to be an attractive method in this
respect (Stenvall et al, 2006; Wikstro ¨m et al, 2007a,b). The
participation rate was unexpectedly high, almost 40% in this study.
In a previous pilot study it was even higher, 58% (Wikstro ¨m et al,
2007a,b). This means that a larger proportion of women with an
increased risk for development of cervical cancer can be included
in the screening programme. It is emphasised that the inclusion of
non-attending women in the screening is of special importance
because of an increased prevalence of high-risk HPV infections in
this category of women (Stenvall et al, 2007). An increased
incidence of cervical cancer has been reported in this group
compared with the participating women (Bos et al, 2006; Lindqvist
et al, 2008).
In addition to the increased coverage obtained by the self-
sampling method, its combination with a test for high-risk HPV
makes it considerably more sensitive in comparison with a
cytological examination. This means that in addition to an
increase in coverage, the women are offered an analytical method
that is more relevant to identify women with an increased risk to
develop cervical cancer as a result of a persistent high-risk HPV
infection. That a single cytological examination has a low
sensitivity is obvious from this investigation, in which 53% of
the women with a biopsy-verified CIN 2–3 lesions on the cervix
showed normal cytology. This also explains why around 25% of all
cases of cervical cancer occur among women regularly participat-
ing in the organised screening (Andrae et al, 2008).
A recent meta-analysis has shown that self-sampling and
sampling by a doctor has equal validity (Petignat et al, 2007). It
seems reasonable to argue that self-sampling in combination with
high-risk HPV analysis of the collected material is not only an
adjunct to sampling of smears, but also a preferable method,
as it both increases the participation rate and more accurately
identifies women at risk. It is known that the efficiency of
cytological screening decreases with age (Gustafsson et al, 1995).
In some studies the majority of post-menopause women with
abnormal smears are HPV negative (Wilander and Wikstro ¨m,
2008). Further, the prevalence of high-risk HPV infections
decreases with age (Wikstro ¨m et al, 2007a,b). For this reason, it
now appears that self-sampling, in combination with HPV testing,
is considerably more sensitive, and also more specific than
cytological screening in middle aged women and older. As HPV
tests are becoming cheaper, primary screening in middle aged and
older women with HPV testing seems to be favourable in all
reasonable respects.
In this study, in agreement with other investigations, it was
evident that the prevalence of high-risk HPV decreased with age,
from over 11% in women o40 years to o3% in women X50 years.
Furthermore, the prevalence was also higher in women performing
self-sampling at home in comparison with women participating in
the organised cytological screening (Forslund et al, 2002). These
facts to a large extent explain why the minority of women not
participating in the organised screening represents around 65% of
all cervical cancer cases (Andrae et al, 2008).
It is well known that HPV testing has a higher sensitivity in
comparison with cytological examinations (Naucler et al, 2007).
This fact is obvious in this investigation, in which 47% of the
women with biopsy-verified CIN 2–3 lesions presented with a
normal cytological smear collected at the same occasion. In
addition, it is emphasised that the specificity of the HPV analysis
increases with age, concomitant with the decreasing prevalence of
persistent HPV infections. This means that at a defined age the
HPV test is both more sensitive and more specific than the
cytological examinations.
This study shows that 43% of the women with a persistent HPV
infection had histological CIN 2–3 lesions on the portio. There was
no obvious age difference, although the number of women with
CIN 2–3 was slightly higher in women o50 years. In total, 2.0% of
all the participating women in the study showed histological CIN
2–3 lesions. In comparison, 0.9% of all cytological smears in the
organised gynaecological screening in Sweden show CIN 2–3 and
the number of histologically verified CIN 2–3 lesions is about the
same (http://ki.se/content/1/c6/05/05/04/Rapport_2006.pdf). This
means that around twice as many CIN 2–3 lesions are detected
with self-sampling combined with testing for high-risk HPV
compared with cytological screening.
In summary, self-sampling at home in combination with a test
for high-risk HPV will increase the number of women participating
in the organised screening for cervical cancer, and also identify
around twice as many CIN 2–3 lesions for treatment with
conisation compared with cytological screening.
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